A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis-Reference-Cited by-同舟云学术

A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis

Published:2016-10-12 Issue:3 Volume:176 Page:577-593
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Ali F.M.¹^ORCID,Cueva A.C.¹²^ORCID,Vyas J.¹^ORCID,Atwan A.A.¹^ORCID,Salek M.S.³⁴^ORCID,Finlay A.Y.¹^ORCID,Piguet V.¹^ORCID

Affiliation:

1. Department of Dermatology and Academic Wound Healing; Division of Infection and Immunity; School of Medicine; Cardiff University; 3rd Floor Glamorgan House, Heath Park Cardiff CF14 4XN U.K

2. Centro de la Piel; Quito Ecuador

3. School of Life and Medical Sciences; University of Hertfordshire; Hatfield U.K

4. Institute for Medicines Development; Cardiff U.K

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.14788/fullpdf

Reference190 articles.

1. Psoriasis: epidemiology, clinical features, and quality of life;Langley;Ann Rheum Dis,2005

2. The effect of severe psoriasis on the quality of life of 369 patients;Finlay;Br J Dermatol,1995

3. Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial;Gordon;JAMA,2003

4. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis;Menter;J Drugs Dermatol,2009

5. Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate-to-severe psoriasis: results from the PRISTINE trial;Thaçi;J Eur Acad Dermatol Venereol,2014

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Properties and Use of the Dermatology Life Quality Index in Patients with Psoriasis;City Healthcare;2023-12-01

2. Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial;Journal of the American Academy of Dermatology;2023-11

3. Application of Dermatology Life Quality Index‐Relevant (DLQI‐R) in patients with moderate‐to‐severe plaque psoriasis treated with tildrakizumab;JEADV Clinical Practice;2023-07-24

4. A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries;British Journal of Dermatology;2023-03-27

5. [Translated article] Evaluation of Dermatology Life Quality Index (DLQI) Scores in Patients With Psoriasis: A Cross-sectional and Correlation Study Over a 6-Year Period;Actas Dermo-Sifiliográficas;2023-03